Drugs / Yinxingmihuan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06224582 | Dec 2020 → Dec 2023 | intermediate coronary syndrome | China National Center for Cardiovascular Diseases | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yinxingmihuan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06224582 ↗ |
| Route | Oral | “standardized medical treatment regimen plus Yinxingmihuan oral solution (oral, 10 ml once, 3 times a day)” NCT06224582 ↗ |